Vivani Medical Inc (VANI) Reports Fourth Quarter and Full Year 2023 Financial ResultsGuruFocus • about 1 month ago
Strategic Shift and Financing Round Highlight VANI's Year-End SummaryRelated Stocks: VANI...
Share to Feed
Vivani Medical, Inc. (Nasdaq: VANI) (Vivani or the Company), a biopharmaceutical company developing miniaturized, long-term drug implants including its lead asset NPM-115 for chronic weight...
Maxim Group analyst Naz Rahman maintained a Buy rating on Vivani Medical (VANI Research Report) yesterday. The company's shares closed yesterday...
Vivani Medical, Inc. (Nasdaq: VANI) (Vivani or the Company), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, today announced the appointment of...
Vivani Medical, Altamira Therapeutics, Quoin Pharmaceuticals among healthcare movers...
Vivani Medical, Inc. (Nasdaq: VANI) ('Vivani' or the 'Company'), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, today...
Vivani Medical (NASDAQ: VANI) stock price surged hard this week after the company published positive results of its ongoing weight loss drug trial. The shares surged from about $1 and reached a high...
Vivani Medical, Inc. (Nasdaq: VANI) (Vivani or the Company), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, today announced positive preclinical...
Vivani Medical, Inc. (NASDAQ:VANI Get Free Report) Director Gregg Williams bought 13,067 shares of the businesss stock in a transaction on Tuesday, January 16th. The stock was bought...